Mail

UK markets closed

FTSE 100
8,433.76
+52.41(+0.63%)
FTSE 250
20,645.38
+114.08(+0.56%)
AIM
789.87
+6.17(+0.79%)
GBP/EUR
1.1622
+0.0011(+0.09%)
GBP/USD
1.2525
+0.0001(+0.01%)
Bitcoin GBP
48,607.84
+34.93(+0.07%)

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

Cadrenal Therapeutics, Inc. (CVKD)

NasdaqCM - NasdaqCM Delayed price. Currency in USD

Add to watchlist

0.4600

-0.0203

(-4.23%)

At close: 04:00PM EDT

0.4502

-0.01

(-2.13%)

After hours:

06:29PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	7.36M
Enterprise value	-1.02M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	0.96
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	-67.38%
S&P500 52-week change ³	26.27%
52-week high ³	3.1400
52-week low ³	0.3600
50-day moving average ³	0.5318
200-day moving average ³	0.6741

Share statistics

Avg vol (3-month) ³	245.28k
Avg vol (10-day) ³	139.31k
Shares outstanding ⁵	16.01M
Implied shares outstanding ⁶	16.01M
Float ⁸	8.02M
% held by insiders ¹	46.72%
% held by institutions ¹	3.63%
Shares short (30 Apr 2024) ⁴	68.49k
Short ratio (30 Apr 2024) ⁴	0.15
Short % of float (30 Apr 2024) ⁴	0.80%
Short % of shares outstanding (30 Apr 2024) ⁴	0.43%
Shares short (prior month 28 Mar 2024) ⁴	42.02k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-102.62%
Return on equity (ttm)	-780.59%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-7.63M
Net income avi to common (ttm)	-8.36M
Diluted EPS (ttm)	N/A
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	8.4M
Total cash per share (mrq)	0.52
Total debt (mrq)	21.35k
Total debt/equity (mrq)	0.28%
Current ratio (mrq)	10.27
Book value per share (mrq)	0.59

Cash flow statement

Operating cash flow (ttm)	-3.53M
Levered free cash flow (ttm)	-3.92M